Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
Ola Landgren(University of Miami Health System), Ingemar Turesson(Spanish Head & Neck Cancer Cooperative Group), Malin Hultcrantz(United States Fish and Wildlife Service), Mark P. Purdue(Government of the United States of America), Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), Ruth M. Pfeiffer(National Institutes of Health), Sydney X. Lu(Memorial Sloan Kettering Cancer Center), Kazunori Murata(Memorial Sloan Kettering Cancer Center), Sean M. Devlin(Memorial Sloan Kettering Cancer Center), Magnus Björkholm(Karolinska Institutet), Dickran Kazandjian(United States Food and Drug Administration), Lakshmi V. Ramanathan(Memorial Sloan Kettering Cancer Center), Even H Rustad(Memorial Sloan Kettering Cancer Center), Jonathan N. Hofmann(National Cancer Institute), Sham Mailankody(Memorial Sloan Kettering Cancer Center), Neha Korde(United States Fish and Wildlife Service), Katie Thoren(Sylvester Comprehensive Cancer Center), Theresia Akhlaghi(Memorial Sloan Kettering Cancer Center), Sigurður Y. Kristinsson(Reykjavík University), Loredana Santo(Division of Cancer Epidemiology and Genetics), Charlene M. McShane(Queen's University Belfast)
Cited by 97
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k